COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,874 Articles (22,568 medRxiv, 8,306 bioRxiv)

Most recent first Previous |  Page 1641: Articles 16401-16410  | Next

COVID-19: A need for new rather than repurposed antiviral drugs.
Kovacs, D., Davis, C., Cannon, P., McFarlane, M., Rainey, S. M., Pinto, R., Stewart, M. E., Szemiel, A. M., Taggart, A., Kohl, A., Marra, F., Thomson, E. C., Scott, J. T.
10.1101/2021.03.25.436935 — Posted: 2021-03-25
Target Capture Sequencing of SARS-CoV-2 Genomes Using the ONETest Coronaviruses Plus
Zhan, S. H., Alamouti, S. M., Kwok, B. S., Lee, M.-H., Khattra, J., Daneshpajouh, H., Houck, H. J., Rand, K. H.
10.1101/2021.03.25.437083 — Posted: 2021-03-25
Computational assessment of the spike protein antigenicity reveals diversity in B cell epitopes but stability in T cell epitopes across SARS-CoV-2 variants
Ge, A., Rioux, M., Kelvin, A. A.
10.1101/2021.03.25.437035 — Posted: 2021-03-25
Sulforaphane exhibits in vitro and in vivo antiviral activity against pandemic SARS-CoV-2 and seasonal HCoV-OC43 coronaviruses
Ordonez, A. A., Bullen, C. K., Villabona-Rueda, A. F., Thompson, E. A., Turner, M. L., Davis, S. L., Komm, O., Powell, J. D., D'Alessio, F. R., Yolken, R. H., Jain, S. K., Jones-Brando, L.
10.1101/2021.03.25.437060 — Posted: 2021-03-25
Freely accessible ready to use global infrastructure for SARS-CoV-2 monitoring
Maier, W., Bray, S., van den Beek, M., Bouvier, D., Coraor, N., Miladi, M., Singh, B., Rambla De Argila, J., Baker, D., Roach, N., Gladman, S., Coppens, F., Martin, D., Lonie, A., Gruning, B., Kosakovsky Pond, S., Nekrutenko, A.
10.1101/2021.03.25.437046 — Posted: 2021-03-25
Genomic surveillance and phylodynamic analyses reveal emergence of novel mutation and co-mutation patterns within SARS-CoV2 variants prevalent in India
Biswas, N., Mallick, P., Maity, S. K., Bhowmik, D., Mitra, A. G., Saha, S., Roy, A., Chakrabarti, P., Paul, S., Chakrabarti, S.
10.1101/2021.03.25.436930 — Posted: 2021-03-25
A robust SARS-CoV-2 replication model in primary human epithelial cells at the air liquid interface to assess antiviral agents
Do, T. N. D., Chatterjee, A. K., Gallay, P. A., Bobardt, M. D., Vangeel, L., De Jonghe, S., Neyts, J., Jochmans, D.
10.1101/2021.03.25.436907 — Posted: 2021-03-25
The Role of Testing Availability on Intentions to Isolate during the COVID-19 Pandemic - A Randomized Trial
Zhang, J. C., Christensen, K. L., Leuchter, R. K., Vangala, S., Han, M., Croymans, D. M.
10.1101/2021.03.22.21251380 — Posted: 2021-03-25
Computational prediction of the effect of amino acid changes on the binding affinity between SARS-CoV-2 spike protein and the human ACE2 receptor
Chen, C., Boorla, V. S., Banerjee, D., Chowdhury, R., Cavener, V. S., Nissly, R. H., Gontu, A., Boyle, N. R., Vandegrift, K., Nair, M. S., Kuchipudi, S. V., Maranas, C. D.
10.1101/2021.03.24.436885 — Posted: 2021-03-25
Efficacy of a Broadly Neutralizing SARS-CoV-2 Ferritin Nanoparticle Vaccine in Nonhuman Primates
Joyce, M. G., King, H. A. D., Elakhal Naouar, I., Ahmed, A., Peachman, K. K., Cincotta, C. M., Subra, C., Chen, R. E., Thomas, P. V., Chen, W.-H., Sankhala, R. S., Hajduczki, A., Martinez, E. J., Peterson, C. E., Chang, W. C., Choe, M., Smith, C., Lee, P. J., Headley, J. A., Taddese, M. G., Elyard, H. A., Cook, A., Anderson, A., McGuckin-Wuertz, K., Dong, M., Swafford, I., Case, J. B., Currier, J. R., Lal, K. G., O'Connell, R. J., Molnar, S., Nair, M. S., Dussupt, V., Daye, S. P., Zeng, X., Barkei, E. K., Staples, H. M., Alfson, K., Carrion, R., Krebs, S. J., Paquin-Proulx, D., Karasavva, N., Polonis, V. R., Jagodzinski, L. L., Amare, M. F., Vasan, S., Scott, P. T., Huang, Y., Ho, D. D., de Val, N., Diamond, M. S., Lewis, M. G., Rao, M., Matyas, G. R., Gromowski, G. D., Peel, S. A., Michael, N. L., Bolton, D. L., Modjarrad, K.
10.1101/2021.03.24.436523 — Posted: 2021-03-25

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).